Round Four Delayed – A Week Off
Today Matt had an oncologist visit to check his blood counts and potentially start round four of six of the
Read More
Author: mattstrongalldaylong
ctDNA Sequencing Could Identify Osteosarcoma Relapse Months Before Any Scan Is Able To
A promising new blood test could help doctors spot when osteosarcoma is coming back. Because osteosarcoma has a highly chaotic
Read More
A Greeting Like No Other
At a recent oncologist visit Matt had to get his vitals checked as well as had to do a blood
Read More
Rice Bioengineer Wins Federal Grant For Ewing Sarcoma Research
Rice University bioengineer Dr. Julea Vlassakis has been awarded a $1.1 million federal grant to advance her research into Ewing
Read More
FDA Grants Full Approval Of Tecelra To Children Battling Synovial Sarcoma
The US Food and Drug Administration (FDA) has granted full approval to a cutting-edge cancer medication called Tecelra and expanded
Read More
Half Way There Livin’ On A Prayer
Matt finished round three of the clinical trial on 6/12 leaving three more rounds to go. Even though it seems
Read More
Combined Inhibition Of CDK4/6 And PI3K Pathways Shows Potential In Ewing Sarcoma
This study published in Translational Oncology explores new drug combinations to treat Ewing Sarcoma. Traditional treatments are often ineffective for
Read More
Blocking MDM2 Could Be The Key To Stopping Some Pediatric Sarcomas
Pediatric sarcomas are notoriously difficult to treat because they lack precise, molecularly targeted therapies. In this study, scientists discovered that
Read More
Researchers Discover New Gene Linked To Kaposi’s Sarcoma
A major scientific breakthrough in rare cancer research was recently made possible by a family’s generous donation. Jim Hindley and
Read More
FDA Agrees To Review Ozekibart For Metastatic Chondrosarcoma
The Food and Drug Administration (FDA) has agreed to review a new drug called Ozekibart to treat a rare and
Read More